{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:57:38Z","timestamp":1781647058540,"version":"3.54.5"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Metabolic changes in kidney failure, including an altered ratio of plasma branched-chain amino acids (BCAAs) to aromatic amino acids (AAAs), also known as Fischer\u2019s ratio (FR), could potentially affect survival. We analyzed associations of FR with mortality in patients with kidney failure. In 328 kidney failure patients starting dialysis (median age 54 years, 60% men), plasma concentrations of BCAAs (valine, isoleucine, and leucine) and AAAs (phenylalanine, tyrosine) were measured using HPLC. We used Fine-Gray competing-risk regression analysis with renal transplantation as competing risk to compare 5-year survival between low and middle tertiles versus high tertile of FR, and restricted cubic spline analysis to examine associations of BCAA, AAA and FR, as continuous variables, with mortality risk. During median 29.4 (range 0.7\u201360.0) months of follow-up, 169 patients (52%) underwent renal transplantation and 82 (25%) patients died. Compared to patients in the high FR tertile, those in the combined middle and low tertiles had higher cumulative incidence of mortality (sHR1.74, 95% CI 1.00\u20133.04,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.04). FR was negatively correlated with inflammation markers and protein-energy wasting. Subgroup and interaction analyses showed that the association of FR with mortality was strongest among patients with cardiovascular disease (OR 4.10, 95% CI 1.53\u201311.00,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.005;\n                    <jats:italic>p<\/jats:italic>\n                    for interaction\u2009=\u20090.009). A low Fischer\u2019s ratio associated with increased mortality risk among individuals with kidney failure and its prognostic strength was most evident in patients with cardiovascular disease.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-46326-y","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T08:25:20Z","timestamp":1775463920000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low Fischer\u2019s ratio is associated with increased mortality in patients with kidney failure"],"prefix":"10.1038","volume":"16","author":[{"given":"Qianying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed E.","family":"Suliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Rashid","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fujia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Troise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"B\u00e1r\u00e1ny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olof","family":"Heimb\u00fcrger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Stenvinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Lindholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"issue":"10225","key":"46326_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"B Bikbov","year":"2020","unstructured":"Bikbov, B. et al. Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395(10225), 709\u2013733 (2020).","journal-title":"Lancet"},{"issue":"10440","key":"46326_CR2","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"AJ Ferrari","year":"2024","unstructured":"Ferrari, A. J. et al. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 403 (10440), 2133\u20132161 (2024).","journal-title":"Lancet"},{"issue":"4","key":"46326_CR3","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1001\/jamainternmed.2022.6817","volume":"183","author":"L Wang","year":"2023","unstructured":"Wang, L. et al. Prevalence of chronic kidney disease in China: results from the sixth China chronic disease and risk factor surveillance. JAMA Intern. Med. 183 (4), 298\u2013310 (2023).","journal-title":"JAMA Intern. Med."},{"issue":"2","key":"46326_CR4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/ckj\/sfac218","volume":"16","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Temporal trends in prevalence and mortality for chronic kidney disease in China from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019. Clin. Kidney J. 16 (2), 312\u2013321 (2023).","journal-title":"Clin. Kidney J."},{"key":"46326_CR5","unstructured":"United States Renal Data System. 2023 USRDS annual data report: Chronic kidney disease in the general population. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. (2023). Available from: https:\/\/usrds-adr.niddk.nih.gov\/2023\/chronic-kidney-disease"},{"key":"46326_CR6","doi-asserted-by":"crossref","unstructured":"Msaad, R. et al. Predictors of mortality in hemodialysis patients. Pan Afr. Med. J. 33(1), 61 (2019).","DOI":"10.11604\/pamj.2019.33.61.18083"},{"issue":"4","key":"46326_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1001\/jamacardio.2019.0375","volume":"4","author":"ZJ Modi","year":"2019","unstructured":"Modi, Z. J. et al. Risk of cardiovascular disease and mortality in young adults with end-stage renal disease: an analysis of the US renal data system. JAMA Cardiol. 4 (4), 353\u2013362 (2019).","journal-title":"JAMA Cardiol."},{"issue":"3","key":"46326_CR8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/ndt\/gfaa128","volume":"36","author":"V Gotta","year":"2021","unstructured":"Gotta, V., Tancev, G., Marsenic, O., Vogt, J. E. & Pfister, M. Identifying key predictors of mortality in young patients on chronic haemodialysis\u2014a machine learning approach. Nephrol. Dialysis Transplantation. 36 (3), 519\u2013528 (2021).","journal-title":"Nephrol. Dialysis Transplantation"},{"issue":"3","key":"46326_CR9","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3390\/jcm13030678","volume":"13","author":"F Mallamaci","year":"2024","unstructured":"Mallamaci, F. & Tripepi, G. Risk factors of chronic kidney disease progression: between old and new concepts. J. Clin. Med. 13 (3), 678 (2024).","journal-title":"J. Clin. Med."},{"issue":"5","key":"46326_CR10","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.kint.2019.07.024","volume":"96","author":"PF Orlandi","year":"2019","unstructured":"Orlandi, P. F. et al. A collaborative, individual-level analysis compared longitudinal outcomes across the International Network of Chronic Kidney Disease (iNETCKD) cohorts. Kidney Int. 96 (5), 1217\u20131233 (2019).","journal-title":"Kidney Int."},{"issue":"4","key":"46326_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.5527\/wjn.v10.i4.59","volume":"10","author":"P Hansrivijit","year":"2021","unstructured":"Hansrivijit, P. et al. Prediction of mortality among patients with chronic kidney disease: A systematic review. World J. Nephrol. 10 (4), 59\u201375 (2021).","journal-title":"World J. Nephrol."},{"issue":"6","key":"46326_CR12","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1111\/j.1523-1755.2005.00338.x","volume":"67","author":"F Mallamaci","year":"2005","unstructured":"Mallamaci, F., Tripepi, G., Cutrupi, S., Malatino, L. S. & Zoccali, C. Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD. Kidney Int. 67 (6), 2330\u20132337 (2005).","journal-title":"Kidney Int."},{"issue":"3","key":"46326_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nrneph.2011.170","volume":"8","author":"A Ortiz","year":"2011","unstructured":"Ortiz, A. et al. Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis. Nat. Rev. Nephrol. 8 (3), 141\u2013150 (2011).","journal-title":"Nat. Rev. Nephrol."},{"issue":"6","key":"46326_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1159\/000368468","volume":"39","author":"F Artunc","year":"2014","unstructured":"Artunc, F. et al. Mortality prediction using modern peptide biomarkers in hemodialysis patients\u2013a comparative analysis. Kidney Blood Press. Res. 39 (6), 563\u2013572 (2014).","journal-title":"Kidney Blood Press. Res."},{"issue":"7","key":"46326_CR15","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.2215\/CJN.10441015","volume":"11","author":"J Sun","year":"2016","unstructured":"Sun, J. et al. Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD. Clin. J. Am. Soc. Nephrol. 11 (7), 1163\u20131172 (2016).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"4","key":"46326_CR16","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.clnu.2010.02.005","volume":"29","author":"G Garibotto","year":"2010","unstructured":"Garibotto, G. et al. Amino acid and protein metabolism in the human kidney and in patients with chronic kidney disease. Clin. Nutr. 29 (4), 424\u2013433 (2010).","journal-title":"Clin. Nutr."},{"issue":"1","key":"46326_CR17","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/ki.1990.174","volume":"38","author":"J Bergstr\u00f6m","year":"1990","unstructured":"Bergstr\u00f6m, J., Alvestrand, A. & F\u00fcrst, P. Plasma and muscle free amino acids in maintenance hemodialysis patients without protein malnutrition. Kidney Int. 38 (1), 108\u2013114 (1990).","journal-title":"Kidney Int."},{"issue":"2","key":"46326_CR18","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/ajcn\/82.2.342","volume":"82","author":"ME Suliman","year":"2005","unstructured":"Suliman, M. E. et al. Inflammation contributes to low plasma amino acid concentrations in patients with chronic kidney disease. Am. J. Clin. Nutr. 82(2), 342\u2013349 (2005).","journal-title":"Am. J. Clin. Nutr."},{"issue":"11","key":"46326_CR19","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1093\/ndt\/12.11.2339","volume":"12","author":"J Divino Filho","year":"1997","unstructured":"Divino Filho, J., Barany, P., Stehle, P., F\u00fcrst, P. & Bergstr\u00f6m, J. Free amino-acid levels simultaneously collected in plasma, muscle, and erythrocytes of uraemic patients. Nephrol Dial Transplant.\u00a012(11), 2339\u20132348 (1997).","journal-title":"Nephrol Dial Transplant."},{"issue":"12","key":"46326_CR20","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s41581-024-00872-8","volume":"20","author":"MG Knol","year":"2024","unstructured":"Knol, M. G., Wulfmeyer, V. C., M\u00fcller, R-U. & Rinschen, M. M. Amino acid metabolism in kidney health and disease. Nat. Rev. Nephrol. 20 (12), 771\u2013788 (2024).","journal-title":"Nat. Rev. Nephrol."},{"key":"46326_CR21","doi-asserted-by":"crossref","unstructured":"Li, X., Zheng, S. & Wu, G. Amino acid metabolism in the kidneys: nutritional and physiological significance. Adv Exp Med Biol. 1265, 71\u201395 (2020).","DOI":"10.1007\/978-3-030-45328-2_5"},{"issue":"1","key":"46326_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2215\/CJN.06000613","volume":"9","author":"F Duranton","year":"2014","unstructured":"Duranton, F. et al. Plasma and urinary amino acid metabolomic profiling in patients with different levels of kidney function. Clin. J. Am. Soc. Nephrol. 9 (1), 37\u201345 (2014).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"1","key":"46326_CR23","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/nu15010184","volume":"15","author":"L Liu","year":"2022","unstructured":"Liu, L. et al. Metabolic homeostasis of amino acids and diabetic kidney disease. Nutrients 15 (1), 184 (2022).","journal-title":"Nutrients"},{"issue":"7991","key":"46326_CR24","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S0140-6736(76)90541-9","volume":"308","author":"P Soeters","year":"1976","unstructured":"Soeters, P. & Fischer, J. Insulin, glucagon, aminoacid imbalance, and hepatic encephalopathy. Lancet 308 (7991), 880\u2013882 (1976).","journal-title":"Lancet"},{"key":"46326_CR25","doi-asserted-by":"crossref","unstructured":"Gervasini G. et al. Prognostic Significance of Amino Acid and Biogenic Amines Profiling in Chronic Kidney Disease. Biomedicines. 11(10), 2775 (2023).","DOI":"10.3390\/biomedicines11102775"},{"issue":"12","key":"46326_CR26","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3390\/tropicalmed7120437","volume":"7","author":"SE Ghanem","year":"2022","unstructured":"Ghanem, S. E. et al. Evaluation of amino acids profile as non-invasive biomarkers of hepatocellular carcinoma in Egyptians. Trop. Med. Infect. Disease. 7 (12), 437 (2022).","journal-title":"Trop. Med. Infect. Disease"},{"issue":"6","key":"46326_CR27","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.jjcc.2019.12.016","volume":"75","author":"H Hiraiwa","year":"2020","unstructured":"Hiraiwa, H. et al. Usefulness of the plasma branched-chain amino acid\/aromatic amino acid ratio for predicting future cardiac events in patients with heart failure. J. Cardiol. 75 (6), 689\u2013696 (2020).","journal-title":"J. Cardiol."},{"key":"46326_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.21037\/tgh.2018.07.06","volume":"3","author":"K Tajiri","year":"2018","unstructured":"Tajiri, K. & Shimizu, Y. Branched-chain amino acids in liver diseases. Translational Gastroenterol. Hepatol. 3, 47 (2018).","journal-title":"Translational Gastroenterol. Hepatol."},{"issue":"5","key":"46326_CR29","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1046\/j.1523-1755.1999.00422.x","volume":"55","author":"P Stenvinkel","year":"1999","unstructured":"Stenvinkel, P. et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 55 (5), 1899\u20131911 (1999).","journal-title":"Kidney Int."},{"issue":"4","key":"46326_CR30","doi-asserted-by":"publisher","first-page":"e0195585","DOI":"10.1371\/journal.pone.0195585","volume":"13","author":"H Mukai","year":"2018","unstructured":"Mukai, H. et al. Restrictive lung disorder is common in patients with kidney failure and associates with protein-energy wasting, inflammation and cardiovascular disease. PLoS One. 13 (4), e0195585 (2018).","journal-title":"PLoS One"},{"issue":"5","key":"46326_CR31","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1177\/0003319713483000","volume":"65","author":"S Ghanavatian","year":"2014","unstructured":"Ghanavatian, S. et al. Subclinical atherosclerosis, endothelial function, and serum inflammatory markers in chronic kidney disease stages 3 to 4. Angiology 65 (5), 443\u2013449 (2014).","journal-title":"Angiology"},{"issue":"5","key":"46326_CR32","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1038\/ki.1996.490","volume":"50","author":"ME Suliman","year":"1996","unstructured":"Suliman, M. E., Anderstam, B. & Bergstr\u00f6m, J. Evidence of taurine depletion and accumulation of cysteinesulfinic acid in chronic dialysis patients. Kidney Int. 50 (5), 1713\u20131717 (1996).","journal-title":"Kidney Int."},{"issue":"3","key":"46326_CR33","first-page":"152","volume":"46","author":"M Dobiasova","year":"2000","unstructured":"Dobiasova, M. & Frohlich, J. The new atherogenic plasma index reflects the triglyceride and HDL-cholesterol ratio, the lipoprotein particle size and the cholesterol esterification rate: changes during lipanor therapy. Vnitr. Lek. 46 (3), 152\u2013156 (2000).","journal-title":"Vnitr. Lek."},{"issue":"3","key":"46326_CR34","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1046\/j.1523-1755.1998.00812.x","volume":"53","author":"AR Qureshi","year":"1998","unstructured":"Qureshi, A. R. et al. Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. Kidney Int. 53 (3), 773\u2013782 (1998).","journal-title":"Kidney Int."},{"issue":"3","key":"46326_CR35","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1177\/0148607191015003252","volume":"15","author":"F Jimenez Jimenez","year":"1991","unstructured":"Jimenez Jimenez, F., Ortiz Leyba, C., Morales Mendez, S., Barros Perez, M. & Munoz Garcia, J. Prospective study on the efficacy of branched-chain amino acids in septic patients. J. Parenter. Enter. Nutr. 15 (3), 252\u2013261 (1991).","journal-title":"J. Parenter. Enter. Nutr."},{"issue":"2","key":"46326_CR36","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1053\/j.jrn.2007.11.011","volume":"18","author":"S Ma\u0142gorzewicz","year":"2008","unstructured":"Ma\u0142gorzewicz, S., D\u0119bska-\u015alizie\u0144, A., Rutkowski, B. & \u0141ysiak-Szyd\u0142owska, W. Serum concentration of amino acids versus nutritional status in hemodialysis patients. J. Ren. Nutr. 18 (2), 239\u2013247 (2008).","journal-title":"J. Ren. Nutr."},{"issue":"5 Suppl","key":"46326_CR37","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1053\/j.jrn.2009.06.014","volume":"19","author":"NJ Cano","year":"2009","unstructured":"Cano, N. J. Branched-chain amino-acid metabolism in renal failure. J. Ren. Nutr. 19 (5 Suppl), S22\u2013S24 (2009).","journal-title":"J. Ren. Nutr."},{"key":"46326_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40104-016-0139-z","volume":"8","author":"S Zhang","year":"2017","unstructured":"Zhang, S., Zeng, X., Ren, M., Mao, X. & Qiao, S. Novel metabolic and physiological functions of branched chain amino acids: a review. J. Anim. Sci. Biotechnol. 8, 1\u201312 (2017).","journal-title":"J. Anim. Sci. Biotechnol."},{"key":"46326_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12986-018-0271-1","volume":"15","author":"M Hole\u010dek","year":"2018","unstructured":"Hole\u010dek, M. Branched-chain amino acids in health and disease: metabolism, alterations in blood plasma, and as supplements.\u00a0Nutr. Metab (Lond). 15, 33 (2018)","journal-title":"Nutr. metabolism"},{"issue":"1","key":"46326_CR40","doi-asserted-by":"publisher","first-page":"6161","DOI":"10.1038\/s41598-023-33377-8","volume":"13","author":"LA Dahabiyeh","year":"2023","unstructured":"Dahabiyeh, L. A. et al. Metabolomics profiling distinctively identified end-stage renal disease patients from chronic kidney disease patients. Sci. Rep. 13 (1), 6161 (2023).","journal-title":"Sci. Rep."},{"issue":"9","key":"46326_CR41","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1093\/ajcn\/31.9.1532","volume":"31","author":"JD Kopple","year":"1978","unstructured":"Kopple, J. D., Jones, M., Fukuda, S. & Swendseid, M. E. Amino acid and protein metabolism in renal failure. Am. J. Clin. Nutr. 31 (9), 1532\u20131540 (1978).","journal-title":"Am. J. Clin. Nutr."},{"issue":"1","key":"46326_CR42","doi-asserted-by":"publisher","first-page":"19184","DOI":"10.1038\/s41598-021-98718-x","volume":"11","author":"C Barba","year":"2021","unstructured":"Barba, C. et al. A low aromatic amino-acid diet improves renal function and prevent kidney fibrosis in mice with chronic kidney disease. Sci. Rep. 11 (1), 19184 (2021).","journal-title":"Sci. Rep."},{"key":"46326_CR43","doi-asserted-by":"crossref","unstructured":"Stan\u010d\u00edkov\u00e1, M., Rovensk\u00fd, J. Metabolism of Aromatic Amino Acids. p. 9\u201312 In: Rovensk\u00fd, J., Urb\u00e1nek, T., O\u013ega, B., Gallagher, J. (eds) Alkaptonuria and Ochronosis. Springer, Cham. (2015)","DOI":"10.1007\/978-3-319-15108-3_4"},{"issue":"6","key":"46326_CR44","doi-asserted-by":"publisher","first-page":"1586S","DOI":"10.1093\/jn\/137.6.1586S","volume":"137","author":"JD Kopple","year":"2007","unstructured":"Kopple, J. D. Phenylalanine and tyrosine metabolism in chronic kidney failure. J. Nutr. 137 (6 Suppl 1):1586S-1590S (2007).\u00a0","journal-title":"J. Nutr."},{"issue":"4","key":"46326_CR45","doi-asserted-by":"publisher","first-page":"954","DOI":"10.3390\/ijms19040954","volume":"19","author":"C Nie","year":"2018","unstructured":"Nie, C., He, T., Zhang, W., Zhang, G. & Ma, X. Branched chain amino acids: beyond nutrition metabolism. Int. J. Mol. Sci. 19 (4), 954 (2018).","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"46326_CR46","doi-asserted-by":"publisher","first-page":"1579S","DOI":"10.1093\/jn\/137.6.1579S","volume":"137","author":"CH Dejong","year":"2007","unstructured":"Dejong, C. H., van de Poll, M. C., Soeters, P. B., Jalan, R. & Damink, S. W. O. Aromatic amino acid metabolism during liver failure. J. Nutr. 137\u00a0(6 Suppl 1):1579S-1585S (2007).","journal-title":"J. Nutr."},{"issue":"11","key":"46326_CR47","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s00726-023-03329-7","volume":"55","author":"F Teymoori","year":"2023","unstructured":"Teymoori, F. et al. Serum branched amino acids and the risk of all-cause mortality: a meta-analysis and systematic review. Amino Acids. 55 (11), 1475\u20131486 (2023).","journal-title":"Amino Acids"},{"issue":"8","key":"46326_CR48","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.3390\/biom13081252","volume":"13","author":"E Fung","year":"2023","unstructured":"Fung, E. et al. Divergent Survival Outcomes Associated with Elevated Branched-Chain Amino Acid Levels among Older Adults with or without Hypertension and Diabetes: A Validated, Prospective, Longitudinal Follow-Up Study. Biomolecules 13 (8), 1252 (2023).","journal-title":"Biomolecules"},{"key":"46326_CR49","doi-asserted-by":"crossref","unstructured":"Rashid, I. et al. Malnutrition as a Potential Predictor of Mortality in Chronic Kidney Disease Patients on Dialysis: A Systematic Review and Meta-Analysis. Clin. Nutr. 43(7), 1760\u20131769 (2024).","DOI":"10.1016\/j.clnu.2024.05.037"},{"issue":"7","key":"46326_CR50","doi-asserted-by":"publisher","first-page":"4022","DOI":"10.3390\/ijms23074022","volume":"23","author":"A Dimou","year":"2022","unstructured":"Dimou, A., Tsimihodimos, V. & Bairaktari, E. The critical role of the branched chain amino acids (BCAAs) catabolism-regulating enzymes, branched-chain aminotransferase (BCAT) and branched-chain \u03b1-keto acid dehydrogenase (BCKD), in human pathophysiology. Int. J. Mol. Sci. 23 (7), 4022 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"46326_CR51","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s00467-008-1046-0","volume":"24","author":"DM Silverstein","year":"2009","unstructured":"Silverstein, D. M. Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease. Pediatr. Nephrol. 24 (8), 1445\u20131452 (2009).","journal-title":"Pediatr. Nephrol."},{"issue":"9","key":"46326_CR52","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/s41430-021-00943-0","volume":"75","author":"D Tom\u00e9","year":"2021","unstructured":"Tom\u00e9, D. Amino acid metabolism and signalling pathways: potential targets in the control of infection and immunity. Eur. J. Clin. Nutr. 75 (9), 1319\u20131327 (2021).","journal-title":"Eur. J. Clin. Nutr."},{"issue":"4","key":"46326_CR53","first-page":"307","volume":"69","author":"M Yoshikawa","year":"1994","unstructured":"Yoshikawa, M. et al. Relationship between nutritional depletion and cell-mediated immune function in active pulmonary tuberculosis. Kekkaku (Tuberculosis). 69(4), 307\u2013316 (1994).","journal-title":"Kekkaku (Tuberculosis)"},{"issue":"5","key":"46326_CR54","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.2215\/CJN.00950208","volume":"3","author":"S Kato","year":"2008","unstructured":"Kato, S. et al. Aspects of immune dysfunction in end-stage renal disease. Clin. J. Am. Soc. Nephrol. 3 (5), 1526\u20131533 (2008).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"2","key":"46326_CR55","doi-asserted-by":"publisher","first-page":"243","DOI":"10.5301\/jn.5000169","volume":"26","author":"W Zhang","year":"2013","unstructured":"Zhang, W. et al. Prognostic role of C-reactive protein and interleukin-6 in dialysis patients: a systematic review and meta-analysis. J. Nephrol. 26 (2), 243\u2013253 (2013).","journal-title":"J. Nephrol."},{"issue":"6","key":"46326_CR56","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.amjmed.2005.10.049","volume":"119","author":"LA Schaap","year":"2006","unstructured":"Schaap, L. A., Pluijm, S. M., Deeg, D. J. & Visser, M. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am. J. Med. 119 (6), 526 (2006). e9\u2013. e17.","journal-title":"Am. J. Med."},{"key":"46326_CR57","doi-asserted-by":"crossref","unstructured":"Kalantar-Zadeh K. What is so bad about reverse epidemiology anyway? Semin Dial. 20(6), 593\u2013601 (2007).","DOI":"10.1111\/j.1525-139X.2007.00360.x"},{"issue":"5","key":"46326_CR58","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/joneph\/21.5.635","volume":"21","author":"M Chmielewski","year":"2008","unstructured":"Chmielewski, M., Carrero, J. J., Nordfors, L., Lindholm, B. & Stenvinkel, P. Lipid disorders in chronic kidney disease: reverse epidemiology and therapeutic approach. J. Nephrol. 21 (5), 635\u2013644 (2008).","journal-title":"J. Nephrol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46326-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46326-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46326-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:31:44Z","timestamp":1781645504000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46326-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["46326"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-46326-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8137084\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Bengt Lindholm was previously affiliated with Baxter Healthcare Corporation. Peter Stenvinkel is or has been on scientific advisory boards of REATA, Baxter, GSK, Astra Zeneca, Invizius, Behring, and Vifor and educational advisory boards for Astellas and FMC. Other authors do not declare any conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"11603"}}